Mizuho Securities analyst Irina Koffler lowered the price target on Allergen (NYSE: AGN) to $200.00 (from $213.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change Analyst PT Change

Credit Suisse Downgrades Allergen (AGN) to NeutralJanuary 31, 2019 4:56 AM Allergen (AGN) PT Lowered to $181 at Raymond JamesJanuary 30, 2019 7:19 AM Allergen (AGN) PT Lowered to $229 at GuggenheimJanuary 30, 2019 7:13 AM Allergen (AGN) PT Lowered to $199 at BofA/Merrill LynchJanuary 30, 2019 6:10 AM Morgan Stanley Downgrades Allergen (AGN) to EqualweightJanuary 30, 2019 5:06 AM Allergen (AGN) PT Lowered to $161 at Piper JaffrayJanuary 30, 2019 4:35 AM UPDATE: RBC Capital Downgrades Allergen (AGN) to Sector Perform; Not Delivering on Growth, Not Unlocking ValueJanuary 30, 2019 12:02 AM Pre-Open Stock Movers 01/29: (SANM) (DDD) (WWD) Higher; (GME) (HOG) (RMBS) Lower (more...)January 29, 2019 9:16 AM Allergan (AGN) in Final Stages of Selling Antibiotics Divisions, Plans to Keep Women's Health Unit - Bloomberg, Citing Conf. CallJanuary 29, 2019 8:43 AM Allergan (AGN) Tops Q4 EPS by 14c, Offers Q1 and FY Guidance, Approves $2B BuybackJanuary 29, 2019 7:04 AM Allergan Reports Fourth Quarter and Full-Year 2018 Financial ResultsJanuary 29, 2019 7:01 AM New BOTOX® Cosmetic (onabotulinumtoxinA) "Own Your Look" Campaign Brings Fresh Face To Trusted BrandJanuary 28, 2019 5:23 PM Allergen (AGN) PT Lowered to $247 at GuggenheimJanuary 28, 2019 6:02 AM Allergan (AGN) call volume and option implied volatility elevated into EPSJanuary 28, 2019 5:48 AM